Positive Health Online
Your Country
Research: KIREMIDJIAN-SCHUMACHER an
Listed in Issue 73
Abstract
KIREMIDJIAN-SCHUMACHER and ROY, Division of Biological Sciences, Medicine and Surgery, New York University College of Dentistry, New York, NY 10010, USA, lk2@nyu.edu, reviewed (30 references) evidence that Se supplementation enhances immune responsiveness during conventional treatment of tumours and the possible additional role of immunotherapy with interleukin-2 (IL-2) in preventing tumour recurrence.
Background
Methodology
Results
Conclusion
References
Kiremidjian-Schumacher L, Roy M. Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions. BioFactors 14 (1-4): 161-8. 2001.